D-0503-2026 Class II Ongoing
FDA drug recall D-0503-2026 was initiated by Wells Pharma Of Houston LLC on Apr 1, 2026 and is designated Class II. Reason for recall: cGMP deviations. The recall status is ongoing. Affected quantity: 4,030 IV Bags.
Recall details
- Product Type
- Drugs
- Report Date
- May 6, 2026
- Initiation Date
- Apr 1, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,030 IV Bags
Product description
fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02.
Reason for recall
cGMP deviations.
Distribution pattern
U.S. Nationwide.
Code information
120925202022769, Expiration Date 04/09/2026, 123125202022883, Expiration Date 05/05/2026, 123125202022884, Expiration Date 05/05/2026 011226202020057, Expiration Date 05/14/2026, 011226202020058, Expiration Date 05/14/2026, 011626202020110, Expiration Date 05/20/2026 012726202020156, Expiration Date 05/28/2026. 012726202020161, Expiration Date 05/28/2026 020226202020195, Expiration Date 06/04/2026 021826202020386, Expiration Date 06/20/2026 022026202020417, Expiration Date 06/24/2026 022026202020424 Expiration Date 06/24/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0503-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026